Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mutation | 7 | 2024 | 867 | 2.400 |
Why?
|
| Retinal Diseases | 3 | 2024 | 47 | 2.250 |
Why?
|
| Retinitis Pigmentosa | 4 | 2025 | 33 | 1.640 |
Why?
|
| Retina | 8 | 2019 | 445 | 1.580 |
Why?
|
| Eye Proteins | 5 | 2020 | 207 | 1.550 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2016 | 68 | 1.290 |
Why?
|
| Macular Degeneration | 3 | 2016 | 85 | 1.240 |
Why?
|
| Electroretinography | 7 | 2022 | 180 | 1.160 |
Why?
|
| Visual Acuity | 6 | 2025 | 119 | 0.980 |
Why?
|
| Visual Fields | 4 | 2025 | 35 | 0.980 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 2 | 2021 | 57 | 0.810 |
Why?
|
| Scotoma | 2 | 2022 | 6 | 0.790 |
Why?
|
| Membrane Proteins | 3 | 2016 | 485 | 0.740 |
Why?
|
| Phenotype | 2 | 2022 | 685 | 0.730 |
Why?
|
| RNA Splicing | 1 | 2021 | 10 | 0.710 |
Why?
|
| Inosine Monophosphate | 1 | 2020 | 1 | 0.660 |
Why?
|
| Retinoschisis | 2 | 2018 | 2 | 0.640 |
Why?
|
| Night Vision | 1 | 2019 | 7 | 0.600 |
Why?
|
| Visual Field Tests | 5 | 2025 | 16 | 0.580 |
Why?
|
| Tomography, Optical Coherence | 5 | 2024 | 96 | 0.560 |
Why?
|
| Child | 6 | 2024 | 2287 | 0.540 |
Why?
|
| Adolescent | 7 | 2025 | 3193 | 0.540 |
Why?
|
| Retinal Degeneration | 1 | 2019 | 156 | 0.520 |
Why?
|
| Middle Aged | 8 | 2025 | 7414 | 0.480 |
Why?
|
| Retinal Photoreceptor Cell Outer Segment | 1 | 2016 | 18 | 0.480 |
Why?
|
| Retinal Rod Photoreceptor Cells | 2 | 2025 | 98 | 0.460 |
Why?
|
| Young Adult | 5 | 2025 | 2833 | 0.450 |
Why?
|
| Retinal Cone Photoreceptor Cells | 2 | 2025 | 131 | 0.440 |
Why?
|
| Synaptosomes | 1 | 2014 | 9 | 0.430 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2014 | 67 | 0.410 |
Why?
|
| Adult | 8 | 2025 | 8024 | 0.400 |
Why?
|
| Dark Adaptation | 2 | 2025 | 13 | 0.390 |
Why?
|
| Male | 9 | 2025 | 13921 | 0.330 |
Why?
|
| Humans | 11 | 2025 | 28851 | 0.320 |
Why?
|
| Aged | 6 | 2025 | 5598 | 0.310 |
Why?
|
| Child, Preschool | 2 | 2024 | 1173 | 0.300 |
Why?
|
| Disease Models, Animal | 4 | 2017 | 1507 | 0.250 |
Why?
|
| Genetic Testing | 1 | 2024 | 68 | 0.220 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2014 | 82 | 0.210 |
Why?
|
| Animals | 5 | 2021 | 10684 | 0.200 |
Why?
|
| Female | 5 | 2025 | 15624 | 0.200 |
Why?
|
| Atrophy | 1 | 2022 | 15 | 0.190 |
Why?
|
| Peripherins | 1 | 2022 | 47 | 0.190 |
Why?
|
| Mice, Knockout | 2 | 2016 | 874 | 0.180 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 1032 | 0.180 |
Why?
|
| GTP Phosphohydrolases | 1 | 2021 | 19 | 0.180 |
Why?
|
| COS Cells | 1 | 2021 | 49 | 0.180 |
Why?
|
| Reproducibility of Results | 2 | 2025 | 787 | 0.170 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 57 | 0.170 |
Why?
|
| Pedigree | 1 | 2020 | 155 | 0.170 |
Why?
|
| IMP Dehydrogenase | 1 | 2020 | 4 | 0.160 |
Why?
|
| Observer Variation | 1 | 2019 | 46 | 0.150 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 50 | 0.150 |
Why?
|
| Disease Progression | 1 | 2020 | 477 | 0.140 |
Why?
|
| Guanidines | 1 | 2017 | 6 | 0.130 |
Why?
|
| Amidines | 1 | 2017 | 8 | 0.130 |
Why?
|
| Benzylamines | 1 | 2017 | 19 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2017 | 40 | 0.130 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2016 | 2 | 0.130 |
Why?
|
| Psychophysics | 1 | 2016 | 10 | 0.120 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 251 | 0.120 |
Why?
|
| Diabetic Retinopathy | 1 | 2017 | 112 | 0.110 |
Why?
|
| Mice | 2 | 2014 | 4802 | 0.110 |
Why?
|
| Synaptic Transmission | 1 | 2014 | 52 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 236 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2014 | 120 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2014 | 117 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2014 | 515 | 0.090 |
Why?
|
| Cattle | 1 | 2014 | 389 | 0.090 |
Why?
|
| Lipids | 1 | 2014 | 218 | 0.090 |
Why?
|
| Photic Stimulation | 1 | 2025 | 71 | 0.060 |
Why?
|
| Contrast Sensitivity | 1 | 2018 | 3 | 0.040 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2018 | 6 | 0.040 |
Why?
|
| Aqueous Humor | 1 | 2017 | 24 | 0.030 |
Why?
|
| Vitreous Body | 1 | 2017 | 23 | 0.030 |
Why?
|
| Intravitreal Injections | 1 | 2017 | 34 | 0.030 |
Why?
|
| Intraocular Pressure | 1 | 2017 | 62 | 0.030 |
Why?
|
| Rabbits | 1 | 2017 | 277 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2017 | 153 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 1280 | 0.030 |
Why?
|
| Quality of Life | 1 | 2018 | 521 | 0.030 |
Why?
|